KL Acquisition Corp
Status: Liquidated
U=S+W/3
W=S@11.5
IPO Proceeds, $M | $287.50M |
---|---|
IPO Date | Jan 8, 2021 |
CEO | Doug Logigian |
Left Lead | Goldman Sachs |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24 months |
IPO Sector |
Healthcare
Healthcare or healthcare-related sectors |
IPO Geography | Global |
Target Company | N/A |
Deal Announced | N/A |
Deal Size, $M | TBD |
Deal Sector | TBD |
Deal Geography | TBD |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | Dec 16, 2022 |
Closing Date | Dec 19, 2022 |
KLAQ
KLAQU
KLAQW
Price | |
---|---|
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on KL Acquisition Corp:
- Structure and cap table
- 7 directors & officers
- 11 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Doug Logigian | 39 | CEO and Chairman |
Richard Gumer | 64 | CFO, Secretary and Director |
David Kho | 34 | Director |
James L. Bierman | 68 | Director |
Gregory D. Casciaro | 64 | Director |
Andrew A. Krakauer | 65 | Director |
Rafael Torres | 47 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Goldman Sachs | BR | 25,000,000 | units |
25,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 11 filings.